Financial advisor Kapil Jain says growing Rs 2 crore to Rs 10 crore requires investors to change their strategy as their ...

Company awaiting comments from FDA by the end of August 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis.

Following U.S. regulatory discussions, accelerated approval strategy remains intact, supported by DENALI Part 2Enrollment completed in Part 2a and 2b of the DENALI trial; Part 2c is enrollingDENALI ...

Defence hardware, electronics and semiconductor production lines are in the crosshairs as the United States moves to block exports from “bad” countries.

Data from Phase 1 SAD clinical trial of ACCG-2671 (oral small molecule dual amylin and calcitonin receptor agonist) and initiation of MAD clinical trial on track for Q3 2026 Topline 72-week ...

A protein known as interleukin 10 (IL-10) is the lynchpin of a new method to protect transplanted cells from host immune ...

Looking for the Best Crypto Prop Trading Firms? We review the top 12 rated firms in 2026 for funding, leverage, and profit ...

Dubai-listed investment firm plans to invest in healthcare and education over three years, betting on GCC demographic growth ...

HSBC sees stronger earnings, resilient domestic demand and a potential return of FII flows supporting its preferred India ...

Discover how nanoflow LC-MS/MS boosts peptide quantitation sensitivity, enabling lower detection limits, and confident ...

Exploring the Benefits and Risks of Buffett’s 90/10 Allocation ...

In 2026 Fantasy Football drafts, we are immensely blessed with talent at the top of draft boards. Ja'Marr Chase and Puka Nacua have been historic PPR producers to begin their careers, and both Bijan ...